Cargando…
Development of Rifapentine-Loaded PLGA-Based Nanoparticles: In vitro Characterisation and in vivo Study in Mice
BACKGROUND: Tuberculosis (TB) is a leading cause of death amongst infectious diseases. The poor response to antitubercular agents necessitates the long-term use of high drug doses, resulting in low patient compliance, which is the main reason for chemotherapy failure and contributes to the developme...
Autores principales: | Liang, Qiuzhen, Xiang, Haibin, Li, Xinyu, Luo, Chunxia, Ma, Xuehong, Zhao, Wenhui, Chen, Jiangtao, Tian, Zheng, Li, Xinxia, Song, Xinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547843/ https://www.ncbi.nlm.nih.gov/pubmed/33116484 http://dx.doi.org/10.2147/IJN.S257758 |
Ejemplares similares
-
Rifapentine-linezolid-loaded PLGA microspheres for interventional therapy of cavitary pulmonary tuberculosis: preparation and in vitro characterization
por: Huang, Jieyun, et al.
Publicado: (2017) -
The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration in vitro and in vivo
por: Li, Zhenbao, et al.
Publicado: (2017) -
Rifapentine-Proliposomes for Inhalation: In Vitro and In Vivo Toxicity
por: Patil-Gadhe, Arpana A., et al.
Publicado: (2014) -
Development of tetracycline-modified nanoparticles for bone-targeted delivery of anti-tubercular drug
por: Liang, Qiuzhen, et al.
Publicado: (2023) -
Development of dual delivery antituberculotic system containing rifapentine microspheres and adipose stem cells seeded in hydroxyapatite/tricalcium phosphate
por: Liang, Qiuzhen, et al.
Publicado: (2019)